what is glp-1 drugs for weight loss medications What Are the Side Effects

FAQs MASH, or metabolic-associated steatohepatitis, is a subtype of MAFLD (metabolic-associated fatty liver disease) characterized by liver inflammation and damage due to fat accumulation

What kind of warnings are currently on these drug labels

In terms of blue-gray dyschromia, light-skinned patients with thin skin are most susceptible to this adverse effect, and it may become more apparent after repeat injections

To evaluate whether integrating IF into a ketogenic framework might mitigate these skeletal effects, rats were fed either a continuous KD or an every-other-day ketogenic diet (EODKD)a regimen combining KD with IF

1,5 Dietary patterns that emphasize healthy fats like olive oil, avocados, nuts, and omega-3 fatty acids effectively maintain GLP-1 activity after meals longer than those heavy in saturated fats, thus supporting better insulin sensitivity and glucose control

This made semaglutide the first GLP-1 RA approved specifically for kidney disease protection, paralleling the role of SGLT2 inhibitors in renal care